V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003211 | 280002414 | 1.71 | 92.6 | Curative (C) | 2017-08-26 | 2017-08-26 | Cetuximab + Radiotherapy Load | 02 | null | 280025184 | CETUXIMAB + RT |
| 280003212 | 280002414 | 1.7 | 63.9 | Curative (C) | 2013-06-27 | 2013-07-03 | CISPLATIN + FLUOROURACIL | 2 | N | 280025184 | CISPLATIN + FLUOROURACIL |
| 280003213 | 280002414 | 1.82 | 90 | Neo-adjuvant (N) | 2017-05-05 | 2017-05-05 | Doxorubicin + Ifosfamide | 2 | N | 280025184 | DOXORUBICIN + IFOSFAMIDE |
| 280003214 | 280002415 | 0 | 57 | Curative (C) | 2015-12-16 | 2015-12-16 | Cisplatin +Fluorouracil (2 wk) | N | N | 280025195 | CISPLATIN + FLUOROURACIL |
| 280003215 | 280002416 | 1.74 | 73 | Neo-adjuvant (N) | 2016-01-31 | 2016-02-01 | Cisplatin +Fluorouracil (3 wk) | N | N | 280025196 | CISPLATIN + FLUOROURACIL |
| 280003216 | 280002416 | null | 81.2 | null | 2017-02-25 | 2017-03-04 | DOXORUBICIN + IFOSFAMIDE | N | N | 280025196 | DOXORUBICIN + IFOSFAMIDE |
| 280003217 | 280002417 | 1.78 | 66 | Neo-adjuvant (N) | 2017-02-19 | 2017-02-24 | Doxorubicin + Ifosfamide | 2 | N | 280025198 | DOXORUBICIN + IFOSFAMIDE |
| 280003218 | 280002418 | 1.62 | 57 | Curative (C) | 2017-09-17 | 2017-10-01 | Doxorubicin + Ifosfamide | null | N | 280025199 | DOXORUBICIN + IFOSFAMIDE |
| 280003219 | 280007261 | 1.71 | null | Curative (C) | 2014-02-02 | 2014-02-03 | Cisplatin + Docetaxel +Fluorouracil | N | null | 280025200 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003220 | 280002419 | 1.8 | 90 | Curative (C) | 2015-08-20 | 2015-08-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280025201 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003221 | 280002419 | 1.74 | 64 | Neo-adjuvant (N) | null | 2016-08-22 | Doxorubicin + Ifosfamide | N | N | 280025201 | DOXORUBICIN + IFOSFAMIDE |
| 280003222 | 280002419 | 1.6 | 100.6 | Palliative (P) | 2018-05-09 | 2018-05-19 | Doxorubicin + Ifosfamide | N | Y | 280025201 | DOXORUBICIN + IFOSFAMIDE |
| 280003223 | 280002419 | 1.8 | 68.7 | Neo-adjuvant (N) | 2016-01-22 | 2016-01-25 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025201 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003224 | 280002420 | 1.59 | 128 | Neo-adjuvant (N) | 2016-03-27 | 2016-04-02 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025206 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003225 | 280002421 | 1.65 | 70 | null | 2017-02-20 | 2017-03-09 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025207 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003226 | 280002422 | 1.67 | 75 | Neo-adjuvant (N) | 2014-09-25 | 2014-09-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025208 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003227 | 280002423 | 1.81 | 70 | Radical (R) | 2017-01-05 | 2017-01-10 | CETUXIMAB + RT | 2 | Y | 280025209 | CETUXIMAB + RT |
| 280003228 | 280007263 | 1.77 | 78.3 | Neo-adjuvant (N) | null | 2015-09-16 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025210 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003229 | 280002424 | 1.61 | 77 | Curative (C) | 2014-05-04 | 2014-05-08 | CETUXIMAB + RT | 02 | null | 280025212 | CETUXIMAB + RT |
| 280003230 | 280002425 | 1.57 | null | Curative (C) | null | 2017-12-15 | CETUXIMAB + RT | N | Y | 280025213 | CETUXIMAB + RT |
| 280003231 | 280002426 | 1.6 | 90 | Curative (C) | 2015-03-16 | 2015-04-20 | CETUXIMAB + RT | N | Y | 280025217 | CETUXIMAB + RT |
| 280003232 | 280002427 | null | null | Curative (C) | 2017-12-08 | 2017-12-25 | Cetuximab + Radiotherapy Load | N | Y | 280025219 | CETUXIMAB + RT |
| 280003233 | 280002428 | null | 52.1 | Palliative (P) | 2016-07-04 | 2016-07-21 | DOXORUBICIN + IFOSFAMIDE | null | N | 280025220 | DOXORUBICIN + IFOSFAMIDE |
| 280003234 | 280002429 | 1.81 | 54.5 | Adjuvant (A) | 2016-01-29 | 2016-01-31 | DOXORUBICIN + IFOSFAMIDE | null | null | 280025223 | DOXORUBICIN + IFOSFAMIDE |
| 280003235 | 280002430 | 1.72 | 92 | Neo-adjuvant (N) | 2014-05-21 | 2014-05-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025224 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003236 | 280002430 | 1.78 | 108 | Palliative (P) | 2014-03-12 | 2014-03-12 | Doxorubicin + Ifosfamide | 02 | null | 280025224 | DOXORUBICIN + IFOSFAMIDE |
| 280003237 | 280002431 | 1.8 | 96.7 | null | 2017-05-21 | 2017-05-28 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025230 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003238 | 280002432 | 1.6 | 94 | Neo-adjuvant (N) | 2017-05-14 | 2017-05-14 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025232 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003239 | 280002433 | 1.69 | null | Curative (C) | 2016-06-03 | 2016-06-05 | Cetuximab + Radiotherapy Load | 02 | N | 280025235 | CETUXIMAB + RT |
| 280003240 | 280002434 | null | 87.9 | Curative (C) | 2014-09-28 | 2014-10-04 | Cetuximab + Radiotherapy Load | N | N | 280025236 | CETUXIMAB + RT |
| 280003241 | 280007265 | null | null | Neo-adjuvant (N) | null | 2015-08-30 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025237 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003242 | 280007265 | 1.69 | 77.7 | Neo-adjuvant (N) | 2016-07-03 | 2016-07-15 | CISPLATIN + FLUOROURACIL | N | N | 280025237 | CISPLATIN + FLUOROURACIL |
| 280003243 | 280002435 | 1.74 | 74.5 | Curative (C) | 2013-08-12 | 2013-08-22 | Cetuximab + Radiotherapy Load | 2 | N | 280025239 | CETUXIMAB + RT |
| 280003244 | 280002436 | 1.8 | 81.6 | Disease modification (D) | 2016-03-11 | 2016-03-19 | DOXORUBICIN + IFOSFAMIDE | 2 | null | 280025240 | DOXORUBICIN + IFOSFAMIDE |
| 280003245 | 280002437 | 1.72 | 46.9 | Adjuvant (A) | 2014-10-11 | 2014-10-23 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025242 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003246 | 280002438 | 1.8 | 107 | Palliative (P) | null | 2017-07-22 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280025243 | CISPLATIN + FLUOROURACIL |
| 280003247 | 280002438 | 1.58 | 76.4 | Neo-adjuvant (N) | 2015-07-21 | 2015-07-22 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025243 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003248 | 280002438 | 1.6 | 99 | Adjuvant (A) | 2015-10-07 | 2015-10-09 | Cisplatin +Fluorouracil (3 wk) | N | Y | 280025243 | CISPLATIN + FLUOROURACIL |
| 280003249 | 280002439 | 1.77 | null | Palliative (P) | null | 2013-10-06 | Doxorubicin + Ifosfamide | N | N | 280025253 | DOXORUBICIN + IFOSFAMIDE |
| 280003250 | 280002440 | 1.75 | 66.8 | Neo-adjuvant (N) | 2016-08-22 | 2016-08-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025254 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003251 | 280002441 | 1.8 | 86.3 | Palliative (P) | 2016-12-21 | 2016-12-24 | DOXORUBICIN + IFOSFAMIDE | 02 | null | 280025256 | DOXORUBICIN + IFOSFAMIDE |
| 280003252 | 280007267 | 1.63 | 87.6 | Curative (C) | 2016-11-11 | 2016-11-23 | Cisplatin +Fluorouracil (2 wk) | N | N | 280025257 | CISPLATIN + FLUOROURACIL |
| 280003253 | 280009718 | 1.9 | 87.7 | Curative (C) | 2015-07-19 | 2015-07-29 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025258 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003254 | 280009718 | 1.65 | 70 | Curative (C) | 2017-08-05 | 2017-09-12 | CETUXIMAB + RT | N | Y | 280025258 | CETUXIMAB + RT |
| 280003255 | 280002442 | 1.66 | 90 | null | 2013-08-16 | 2013-08-29 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025260 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003256 | 280002443 | 1.51 | 63.1 | Palliative (P) | 2014-03-14 | 2014-03-14 | CETUXIMAB + RT | 02 | null | 280025261 | CETUXIMAB + RT |
| 280003257 | 280007268 | 1.71 | 50.2 | Neo-adjuvant (N) | 2013-03-13 | 2013-04-02 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025264 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003258 | 280002444 | 1.79 | 96.4 | Palliative (P) | 2016-05-23 | 2016-05-28 | Doxorubicin + Ifosfamide | 2 | N | 280025266 | DOXORUBICIN + IFOSFAMIDE |
| 280003259 | 280002445 | 1.75 | null | Disease modification (D) | 2014-01-01 | 2014-01-01 | Doxorubicin + Ifosfamide | N | N | 280025267 | DOXORUBICIN + IFOSFAMIDE |
| 280003260 | 280002445 | null | null | Curative (C) | 2014-10-17 | 2014-11-01 | CETUXIMAB + RT | null | null | 280025267 | CETUXIMAB + RT |